COGNIZANT TECHNOLOGY SOLUTIONS CORP

CTSH 10-K · FY 2025

CTSH FY 2025 request

Playground key active
Request URL /api/financials?ticker=CTSH&year=2025&quarter=4&full_year_mode=true
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric FY 2025 FY 2024 YoY
Revenue 21,108 19,736 +7.0%
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization 13,991 12,958 +8.0%
Selling, General & Administrative 3,240 3,223 +0.5%
Depreciation And Amortization 550 529 +4.0%
Operating Income 3,389 2,892 +17.2%
Show Business Segments breakouts
Communications, Media and Technology · Operating Segments 436 393 +10.9%
Financial Services · Operating Segments 1,233 915 +34.8%
Health Sciences · Operating Segments 1,029 1,073 -4.1%
Products and Resources · Operating Segments 787 771 +2.1%
Show Consolidation Items breakouts
Operating Segments 3,485 3,152 +10.6%
Investment Income Interest And Dividend 105 119 -11.8%
Interest Expense -37 -54 +31.5%
Foreign Currency Transaction Gain Loss Before Tax 18 -19 +194.7%
Other Non-Operating Income (Expense) 4
Non-Operating Income (Expense) 90 46 +95.7%
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 3,479 2,938 +18.4%
Income Tax Expense (Benefit) -1,258 -713 -76.4%
Income Loss From Equity Method Investments 9 15 -40.0%
Net Income 2,230 2,240 -0.4%
Show Equity Components breakouts
Retained Earnings 2,230 2,240 -0.4%
EPS (Basic) 4.57 4.52 +1.1%
EPS (Diluted) 4.56 4.51 +1.1%
Wtd Avg Shares (Basic) 488 496 -1.6%
Weighted Average Number Diluted Shares Outstanding Adjustment 1 1 0.0%
Wtd Avg Shares (Diluted) 489 497 -1.6%
Gain Loss On Sale Of Property Plant Equipment -62
Revenue 21,108 19,736 +7.0%
Show Product Lines breakouts
Consulting And Technology Services [Member] 13,533 12,492 +8.3%
Consulting And Technology Services [Member] · Communications, Media and Technology 1,820 1,821 -0.1%
Consulting And Technology Services [Member] · Financial Services 4,365 4,022 +8.5%
Consulting And Technology Services [Member] · Health Sciences 3,651 3,456 +5.6%
Consulting And Technology Services [Member] · Products and Resources 3,697 3,193 +15.8%
Outsourcing Services [Member] 7,575 7,244 +4.6%
Outsourcing Services [Member] · Communications, Media and Technology 1,483 1,448 +2.4%
Outsourcing Services [Member] · Financial Services 1,808 1,731 +4.4%
Outsourcing Services [Member] · Health Sciences 2,696 2,476 +8.9%
Outsourcing Services [Member] · Products and Resources 1,588 1,589 -0.1%
Show Business Segments breakouts
Communications, Media and Technology 3,303 3,269 +1.0%
Communications, Media and Technology · Europe 614 666 -7.8%
Communications, Media and Technology · Europe, excluding United Kingdom [Member] 133 155 -14.2%
Communications, Media and Technology · Fixed Price Contract 1,365 1,324 +3.1%
Communications, Media and Technology · GB 481 511 -5.9%
Communications, Media and Technology · North America 2,361 2,279 +3.6%
Communications, Media and Technology · Operating Segments 3,303 3,269 +1.0%
Communications, Media and Technology · Rest of World [Member] 328 324 +1.2%
Communications, Media and Technology · Time And Materials Contract 1,771 1,775 -0.2%
Communications, Media and Technology · Transaction Or Volume-Based [Member] 167 170 -1.8%
Financial Services 6,173 5,753 +7.3%
Financial Services · Europe 1,283 1,185 +8.3%
Financial Services · Europe, excluding United Kingdom [Member] 640 613 +4.4%
Financial Services · Fixed Price Contract 2,811 2,384 +17.9%
Financial Services · GB 643 572 +12.4%
Financial Services · North America 4,380 4,075 +7.5%
Financial Services · Operating Segments 6,173 5,753 +7.3%
Financial Services · Rest of World [Member] 510 493 +3.4%
Financial Services · Time And Materials Contract 3,161 3,188 -0.8%
Financial Services · Transaction Or Volume-Based [Member] 201 181 +11.0%
Health Sciences 6,347 5,932 +7.0%
Health Sciences · Europe 881 745 +18.3%
Health Sciences · Europe, excluding United Kingdom [Member] 667 559 +19.3%
Health Sciences · Fixed Price Contract 3,149 2,878 +9.4%
Health Sciences · GB 214 186 +15.1%
Health Sciences · North America 5,311 5,072 +4.7%
Health Sciences · Operating Segments 6,347 5,932 +7.0%
Health Sciences · Rest of World [Member] 155 115 +34.8%
Health Sciences · Time And Materials Contract 1,978 1,968 +0.5%
Health Sciences · Transaction Or Volume-Based [Member] 1,220 1,086 +12.3%
Products and Resources 5,285 4,782 +10.5%
Products and Resources · Europe 1,234 1,163 +6.1%
Products and Resources · Europe, excluding United Kingdom [Member] 650 605 +7.4%
Products and Resources · Fixed Price Contract 2,685 2,442 +10.0%
Products and Resources · GB 584 558 +4.7%
Products and Resources · North America 3,728 3,272 +13.9%
Products and Resources · Operating Segments 5,285 4,782 +10.5%
Products and Resources · Rest of World [Member] 323 347 -6.9%
Products and Resources · Time And Materials Contract 2,239 1,995 +12.2%
Products and Resources · Transaction Or Volume-Based [Member] 361 345 +4.6%
Show Geography breakouts
Europe 4,012 3,759 +6.7%
Europe, excluding United Kingdom [Member] 2,090 1,932 +8.2%
GB 1,922 1,827 +5.2%
North America 15,780 14,698 +7.4%
Rest of World [Member] 1,316 1,279 +2.9%
Show Consolidation Items breakouts
Operating Segments 21,108 19,736 +7.0%
Show Contract With Customer Basis Of Pricing breakouts
Fixed Price Contract 10,010 9,028 +10.9%
Time And Materials Contract 9,149 8,926 +2.5%
Transaction Or Volume-Based [Member] 1,949 1,782 +9.4%
Operating Expenses (FY)
Show Consolidation Items breakouts
Corporate Non Segment 96 260 -63.1%
Comprehensive Income 2,366 2,038 +16.1%
Other Comprehensive Income 136 -202 +167.3%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent -38 -35 -8.6%
Accumulated Other Comprehensive Income 136 -202 +167.3%

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash & Cash Equivalents 1,901 2,231 -14.8%
Short-Term Investments 13 12 +8.3%
Accounts Receivable 4,439 4,059 +9.4%
Other Assets Current 1,465 1,202 +21.9%
Total Current Assets 7,818 7,504 +4.2%
Non-Current Assets
Property, Plant & Equipment 933 994 -6.1%
Operating Lease Right-of-Use Assets 573 552 +3.8%
Goodwill 7,106 6,953 +2.2%
Show Business Segments breakouts
Communications, Media and Technology 1,080 1,045 +3.3%
Financial Services 1,177 1,129 +4.3%
Health Sciences 2,915 2,895 +0.7%
Products and Resources 1,934 1,884 +2.7%
Deferred Tax Assets 967 1,248 -22.5%
Long Term Investments 111 90 +23.3%
Other Non-Current Assets 1,767 1,026 +72.2%
Total Assets 20,692 19,966 +3.6%
Intangible Assets (Q)
Show Finite Lived Intangible Assets By Major Class breakouts
Customer Relationships 1,283 1,466 -12.5%
Developed Technology Rights 8 5 +60.0%
Finite lived trademarks and other 10 12 -16.7%
Other Assets
Intangible Assets Net Excluding Goodwill 1,417 1,599 -11.4%
Current Liabilities
Accounts Payable 308 340 -9.4%
Deferred Revenue 501 450 +11.3%
Operating Lease Liability Current 153 152 +0.7%
Total Current Liabilities 3,659 3,585 +2.1%
Current Portion of Long-Term Debt (Q)
Show Debt Instrument breakouts
Credit Agreement [Member] · Loans Payable 33 33 0.0%
Non-Current Liabilities
Deferred Revenue Noncurrent 37 30 +23.3%
Operating Lease Liabilities 423 420 +0.7%
Deferred Tax Liabilities 168 154 +9.1%
Long-Term Debt 543 875 -37.9%
Other Non-Current Liabilities 847 494 +71.5%
Total Liabilities 5,677 5,558 +2.1%
Long-Term Debt (Q)
Show Debt Instrument breakouts
Credit Agreement [Member] · Loans Payable 577 610 -5.4%
Other Liabilities
Short Term Borrowings 33 33 0.0%
Accrued Liabilities And Other Liabilities 2,664 2,610 +2.1%
Stockholders' Equity
Common Stock 5 5 0.0%
Additional Paid-In Capital 12 13 -7.7%
Retained Earnings 15,158 14,686 +3.2%
Accumulated Other Comprehensive Income -160 -296 +45.9%
Total Stockholders' Equity 15,015 14,408 +4.2%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment Net Unamortized Gain Loss -109 -17 -541.2%
Accumulated Gain Loss Net Cash Flow Hedge Parent -63 -25 -152.0%
Accumulated Other Comprehensive Income -160 -296 +45.9%
Accumulated Translation Adjustment 12 -254 +104.7%
Additional Paid In Capital 12 13 -7.7%
Common Stock 5 5 0.0%
Retained Earnings 15,158 14,686 +3.2%
Total Liabilities & Equity 20,692 19,966 +3.6%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Depreciation & Amortization 550 542 +1.5%
Deferred Income Taxes 327 -355 +192.1%
Stock-Based Compensation 181 175 +3.4%
Other Non-Cash Items -5 32 -115.6%
Change in Accounts Receivable -366 -49 -646.9%
Increase Decrease In Other Operating Assets -118 -386 +69.4%
Change in Accounts Payable -2 -23 +91.3%
Increase Decrease In Deferred Revenue 55 44 +25.0%
Increase Decrease In Other Operating Liabilities 93 -96 +196.9%
Net Cash from Operations 2,883 2,124 +35.7%
Investing Activities
Capital Expenditures -288 -297 +3.0%
Payments To Acquire Other Investments -17 -2 -750.0%
Proceeds From Sale And Maturity Of Other Investments 5 265 -98.1%
Proceeds From Sale Of Property Plant And Equipment 70
Net Cash from Investing -230 -1,646 +86.0%
Financing Activities
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options 58 63 -7.9%
Share Repurchases -1,378 -605 -127.8%
Repayments Of Debt And Capital Lease Obligations -42 -73 +42.5%
Repayments Of Long Term Lines Of Credit -300 -300 0.0%
Payments Of Dividends Common Stock -610 -600 -1.7%
Net Cash from Financing -2,272 -915 -148.3%
Supplemental
Income Taxes Paid 985 1,120 -12.1%
Interest Paid 36 53 -32.1%
Income Taxes Paid 985
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 22 -49 +144.9%
Net Change in Cash 403 -486 +182.9%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2,634 2,231 +18.1%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key